Forte Biosciences, Inc. (NASDAQ:FBRX) showed up in the 13F filings of 35 institutional investors as of June 2024.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 2,376,120 | 950,335 | 66.65% | $61,624,672.00 |
| Federated Hermes, Inc. | 31 Mar, 2026 | 1,765,516 | 0 | 0.00% | $45,726,864.00 |
| FRED ALGER MANAGEMENT, LLC | 31 Mar, 2026 | 1,273,965 | -187,006 | -12.80% | $32,995,694.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 1,196,955 | 0 | 0.00% | $31,001,135.00 |
| Affinity Asset Advisors, LLC | 31 Mar, 2026 | 1,011,890 | 22,400 | 2.26% | $26,207,951.00 |
| MPM BioImpact LLC | 31 Mar, 2026 | 1,000,682 | 1,000,682 | 0.00% | $25,917,664.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Mar, 2026 | 950,000 | 616,667 | 185.00% | $24,605,000.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 531,692 | 531,692 | 0.00% | $13,770,823.00 |
| Morgan Stanley | 31 Mar, 2026 | 500,298 | 429,767 | 609.33% | $12,957,718.00 |
| Cable Car Capital, LP | 31 Mar, 2026 | 400,000 | 0 | 0.00% | $10,360,000.00 |
| FMR LLC | 31 Mar, 2026 | 340,695 | 29,730 | 9.56% | $8,824,001.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 337,983 | 91,298 | 37.01% | $8,753,760.00 |
| Woodline Partners LP | 31 Mar, 2026 | 331,987 | 0 | 0.00% | $8,598,463.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 233,369 | 233,369 | 0.00% | $6,044,257.00 |
| AWM Investment Company, Inc. | 31 Mar, 2026 | 200,000 | -36,821 | -15.55% | $5,180,000.00 |
| SPHERA FUNDS MANAGEMENT LTD. | 31 Mar, 2026 | 184,984 | -885 | -0.48% | $4,791,086.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 150,307 | 114,010 | 314.10% | $3,892,953.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 150,000 | 150,000 | 0.00% | $3,885,000.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 133,494 | 80,580 | 152.28% | $3,457,495.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 125,442 | 833 | 0.67% | $3,250,628.00 |